Characterization and Pharmacological Evaluation of Anti-Cellulite Herbal Product(s) Encapsulated in 3D-Fabricated Polymeric Microneedles
| dc.Affiliation | October University for modern sciences and Arts (MSA) | |
| dc.contributor.author | I.Amer, Reham | |
| dc.contributor.author | El-Osaily, Ghada H. | |
| dc.contributor.author | Bakr, Riham Omar | |
| dc.contributor.author | El Dine, Riham Salah | |
| dc.contributor.author | Fayez, Ahmed | |
| dc.date.accessioned | 2020-04-23T07:34:02Z | |
| dc.date.available | 2020-04-23T07:34:02Z | |
| dc.date.issued | 2020-12 | |
| dc.description.abstract | Skin health is vital for a healthy body. Herbal remedies have long been used for skin care, and their global use has tremendously increased over the past three decades. Although cellulite is seen as a normal condition by the medical community, it is considered a serious cosmetic concern for most afected women. Many topical anti-cellulite creams are available on the market, but unfortunately, their efcacy has not been proven scientifcally. Microneedles (MNs) represent a new approach to enhance the permeation of loaded medication through the skin. In this study, the anti-cellulite efects of Vitex agnus-castus and Tamarindus indica extracts were compared using safe and efective polymeric MNs. This delivery system ofers a painless alternative to the combined treatment strategy of microneedling devices and anti-cellulite products. The selected standardized extracts were evaluated for their mineral, phenolic and favonoid contents, which are correlated to a promising antioxidant efect, as demonstrated by an in vitro radical scavenging activity assay. 3D-printing techniques were chosen for fabrication of a micromold, which is inexpensive for mass production. To ensure that MNs were sufciently strong to perforate the skin without breaking, axial failure force was measured using a micro-mechanical test machine. The anticellulite efects of MNs were assessed using an in vivo diet- induced obesity guinea pig model. Skin properties, histopathology and infammatory markers were examined. MNs loaded with plant extracts were statistically comparable in normalizing the oxidative state and reducing infammation, while myeloperoxidase levels were more signifcantly reduced by T. indica than by V. agnus-castus. This novel delivery system opens the door for new transdermal strategies for cellulite management | en_US |
| dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=21100200805&tip=sid&clean=0 | |
| dc.identifier.citation | Emanuele, E., Bertona, M. & Geroldi, D. A multilocus candidate approach identifes ACE and HIF1A as susceptibility genes for cellulite. J. Eur. Acad. Dermatology Venereol 24, 930–935, https://doi.org/10.1111/j.1468-3083.2009.03556.x. (2010). 2. Rawlings, A. V. Cellulite and its treatment. Int. J. Cosmet. Sci. 28, 175–190, https://doi.org/10.1111/j.1467-2494.2006.00318.x. (2006). Mirrashed, F., Sharp, J. C., Krause, V., Morgan, J. & Tomanek, B. Pilot study of dermal and subcutaneous fat structures by MRI in individuals who differ gender, BMI, and cellulite grading. Ski. Res. Technol 10, 161–168, https://doi.org/10.1111/ j.1600-0846.2004.00072.x (2004). 4. Kruglikov, I. Te Pathophysiology of Cellulite: Can the Puzzle Eventually Be Solved? J. Cosmet. Dermatological Sci. Appl 2, 1–7, https://doi.org/10.4236/jcdsa.2012.21001. (2012). 5. de la Casa Almeida, M., Suarez Serrano, C., Rebollo Roldán, J. & Jiménez Rejano, J. J. Cellulite’s aetiology: a review. J. Eur. Acad. Dermatology Venereol 27, 273–278, https://doi.org/10.1111/j.1468-3083.2012.04622.x. (2013). 6. Doris Hexsel, Débora Zechmeister do Prado, and. Topical Management of Cellulite. In Cellulite: Pathophysiology and treatment (ed. Mitchel P. & Goldman, D. H.) 73–79 (CRC Press, 2010). https://doi.org/10.3109/9781439802724-11. 7. Sullivan, S. P., Murthy, N. & Prausnitz, M. R. Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv. Mater. 20, 933–938, https://doi.org/10.1002/adma.200701205 (2008). 8. Prausnitz, M. R., Mitragotri, S. & Langer, R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. 3, 115–124, https://doi.org/10.1038/nrd1304 (2004). 9. Bhatnagar, S., Dave, K. & Venuganti, V. V. K. Microneedles in the clinic. J. Control. Release 260, 164–182, https://doi.org/10.1016/j. jconrel.2017.05.029. (2017). 10. Ye, Y., Yu, J., Wen, D. & Kahkoska, A. R. Polymeric microneedles for transdermal protein delivery. Adv. Drug Deliv. Rev. 127, 106–118, https://doi.org/10.1016/j.addr.2018.01.015 (2018). 11. Ita, K. Dissolving microneedles for transdermal drug delivery: Advances and challenges. Biomed. Pharmacother. 93, 1116–1127, https://doi.org/10.1016/j.biopha.2017.07.019 (2017). 12. Haj-Ahmad, R. et al. Microneedle coating techniques for transdermal drug delivery. Pharmaceutics 7, 486–502, https://doi. org/10.3390/pharmaceutics7040486. (2015). 13. Strambini, L. M., Longo, A., Diligenti, A. & Barillaro, G. A minimally invasive microchip for transdermal injection/sampling applications. Lab Chip 12, 3370, https://doi.org/10.1039/c2lc40348j. (2012). 14. Strambini, L. M. et al. Self-powered microneedle-based biosensors for pain-free high-accuracy measurement of glycaemia in interstitial fuid. Biosens. Bioelectron 66, 162–168, https://doi.org/10.1016/j.bios.2014.11.010 (2015). 15. Ventrelli, L., Marsilio Strambini, L. & Barillaro, G. Microneedles for transdermal biosensing: Current picture and future direction. Adv. Healthc. Mater 4, 2606–2640, https://doi.org/10.1002/adhm.201500450. (2015). 16. Ito, Y., Hagiwara, E., Saeki, A., Sugioka, N. & Takada, K. Feasibility of microneedles for percutaneous absorption of insulin. Eur. J. Pharm. Sci. 29, 82–88, https://doi.org/10.1016/j.ejps.2006.05.011 (2006). 17. Kim, Y.-C., Park, J.-H. & Prausnitz, M. R. Microneedles for drug and vaccine delivery. Adv. Drug Deliv. Rev. 64, 1547–1568, https:// doi.org/10.1016/j.addr.2012.04.005. (2012). 18. Wang, M., Hu, L. & Xu, C. Recent advances in the design of polymeric microneedles for transdermal drug delivery and biosensing. Lab Chip 17, 1373–1387, https://doi.org/10.1039/C7LC00016B (2017). 19. Cheung, K. & Das, D. B. Microneedles for drug delivery: trends and progress. Drug Deliv. 23, 1–17, https://doi.org/10.3109/107175 44.2014.986309 (2014). 20. Moga, K. A. et al. Rapidly-dissolvable microneedle patches via a highly scalable and reproducible sof lithography approach. Adv. Mater. 25, 5060–5066, https://doi.org/10.1002/adma.201300526. (2013). 21. Economidou, S. N. et al. 3D printed microneedle patches using stereolithography (SLA) for intradermal insulin delivery. Mater. Sci. Eng. C 102, 743–755, https://doi.org/10.1016/j.msec.2019.04.063 (2019). 22. SLA 3D Printing: Stereolithography Simply Explained | All3DP. All3DP (2019). Available at: https://all3dp.com/2/stereolithography- 3d-printing-simply-explained/. (Accessed: 10th November 2019). 23. Ita, K. Transdermal delivery of drugs with microneedles—potential and challenges. Pharmaceutics 7, 90–105, https://doi. org/10.3390/pharmaceutics7030090. (2015). 24. Waqas, M. K. et al. Fabrication of Tamarindus indica seeds extract loaded-cream for photo-aged skin: Visioscan®. studies. Postep. Dermatologii i Alergol. 34, 339–345, https://doi.org/10.5114/ada.2017.69314. (2017). 25. Razali, N., Abdul Aziz, A., Lim, C. Y. & Mat Junit, S. Investigation into the efects of antioxidant-rich extract of Tamarindus indica leaf on antioxidant enzyme activities, oxidative stress and gene expression profles in HepG2 cells. PeerJ e1292, 1–35, https://doi. org/10.7717/peerj.1292. (2015). 26. Tril, U., Fernández-López, J., Álvarez, J. Á. P. & Viuda-Martos, M. Chemical, physicochemical, technological, antibacterial and antioxidant properties of rich-fbre powder extract obtained from tamarind (Tamarindus indica L.). Ind. Crops Prod 55, 155–162, https://doi.org/10.1016/j.indcrop.2014.01.047 (2014). 27. Suralkar, A. A., Rodge, K. N., Kamble, R. D. & Maske, K. S. Evaluation of Anti-infammatory and Analgesic Activities of Tamarindus indica Seeds. Int. J. Pharm. Sci. Drug Res. 4, 213–217. http://www.doc-developpement-durable.org/fle/Arbres-Fruitiers/FICHES_ ARBRES/tamarinier/Evaluation%20of%20Anti-inflammatory%20and%20Analgesic%20Activities%20of%20Tamarindus%20 indica.pdf (2012). 28. Rodriguez Amado, J. R. et al. Antioxidant and hepatoprotective activity of a new tablets formulation from Tamarindus indica L. Evidence-Based Complement. Altern. Med. 2016, Article ID 3918219, 7 pages. https://doi.org/10.1155/2016/3918219 (2016). 29. Martinello, F. et al. Hypolipemic and antioxidant activities from Tamarindus indica L. pulp fruit extract in hypercholesterolemic hamsters. Food Chem. Toxicol. 44, 810–818, https://doi.org/10.1016/j.fct.2005.10.011 (2006). 30. Sudjaroen, Y. et al. Isolation and structure elucidation of phenolic antioxidants from Tamarind (Tamarindus indica L.) seeds and pericarp. Food Chem. Toxicol. 43, 1673–1682, https://doi.org/10.1016/j.fct.2005.05.013 (2005). 31. Bhadoriya, S. S., Ganeshpurkar, A., Narwaria, J., Rai, G. & Jain, A. P. Tamarindus indica: Extent of explored potential. Pharmacogn. Rev 5, 73–81, https://doi.org/10.4103/0973-7847.79102. (2011). 32. Waqas, M. K. et al. Fabrication of Tamarindus indica seeds extract loaded-cream for photo-aged skin: Visioscan® studies. Postep. dermatologii i Alergol. 34, 339–345, https://doi.org/10.5114/ada.2017.69314 (2017). 33. Mari, A. et al. Metabolic profling of Vitex agnus castus leaves, fruits and sprouts: Analysis by LC/ESI/(QqQ)MS and (HR) LC/ESI/ (Orbitrap)/MSn. J. Pharm. Biomed. Anal. 102, 215–221, https://doi.org/10.1016/j.jpba.2014.09.018 (2015). 34. Sağlam, H., Pabuçcuoğlu, A. & Kıvçak, B. Antioxidant activity of Vitex agnus-castus L. extracts. Phyther. Res 21, 1059–1060, https:// doi.org/10.1002/ptr.2211 (2007). 35. Niroumand, M., Heydarpour, F. & Farzaei, M. Pharmacological and therapeutic effects of Vitex agnus-castus L.: A review. Pharmacogn. Rev 12, 103, https://doi.org/10.4103/phrev.phrev_22_17 (2018). 36. Duymuş, H. G., Çifçi, G. A., Yildirim, Ş. U., Demirci, B. & Kirimer, N. Te cytotoxic activity of Vitex agnus castus L. essential oils and their biochemical mechanisms. Ind. Crops Prod 55, 33–42, https://doi.org/10.1016/j.indcrop.2014.01.041 (2014). 37. Azadbakht, M., Baheddini, A., Shorideh, S. M. & Naserzadeh, A. Efect of Vitex agnus - castus L. leaf and fruit favonoidal extracts on serum prolactin concentration. J. Med. Plants 4, 56–61 (2005). 38. Schmid, D., Wandrey, F. & Zülli, F. Stimulating endorphins and sex hormones in the skin. Personal care 49–51. https://www. personalcaremagazine.com/story/24681/stimulating-endorphins-and-sex-hormones-in-the-skin (2017). 39. Kuruüzüm-Uz, A., Ströch, K., Demirezer, L. Ö. & Zeeck, A. Glucosides from Vitex agnus-castus. Phytochemistry 63, 959–964, https:// doi.org/10.1016/s0031-9422(03)00285-1 (2003). 40. Zoghbi, M. das G. B., Andrade, E. H. A. & Maia, J. G. S. Te essential oil of Vitex agnus-castus L. growing in the Amazon region. Flavour Fragr. J. 14, 211–213. 10.1002/(SICI)1099-1026(199907/08)14:4<211 | en_US |
| dc.identifier.doi | https://doi.org/10.1038/s41598-020-63271-6 | |
| dc.identifier.other | https://doi.org/10.1038/s41598-020-63271-6 | |
| dc.identifier.uri | https://t.ly/zV9S | |
| dc.language.iso | en_US | en_US |
| dc.publisher | nature | en_US |
| dc.relation.ispartofseries | Scientific Reports;10(1) | |
| dc.subject | Pharmacological Evaluation | en_US |
| dc.subject | Anti-Cellulite Herbal | en_US |
| dc.subject | 3D-Fabricated Polymeric Microneedles | en_US |
| dc.title | Characterization and Pharmacological Evaluation of Anti-Cellulite Herbal Product(s) Encapsulated in 3D-Fabricated Polymeric Microneedles | en_US |
| dc.type | Article | en_US |